Mycoplasma pneumoniae central nervous system infections

Current Opinion in Neurology

Volumn 19, Issue 4, 2006, Pages 374-378

  Daxboeck, Florian ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cerebrospinal fluid; Encephalitis; Mycoplasma pneumoniae; Polymerase chain reaction; Serology

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; IMMUNOGLOBULIN; KETOLIDE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC THERAPY; ANTIBODY PRODUCTION; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; CYTOKINE PRODUCTION; ENCEPHALITIS; HUMAN; IMMUNE SYSTEM; IMMUNOADSORPTION; INTRACRANIAL HYPERTENSION; KLUVER BUCY SYNDROME; MYCOPLASMA PNEUMONIAE; NONHUMAN; PATHOGENESIS; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; REVIEW; SEROLOGY;

ANTI-BACTERIAL AGENTS; CENTRAL NERVOUS SYSTEM INFECTIONS; HUMANS; MYCOPLASMA INFECTIONS; MYCOPLASMA PNEUMONIAE;

EID: 33747371397     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wco.0000236617.04958.60     Document Type: Review

References (56)

1. Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 1993; 17 (Suppl 1):S37-S46.
2. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004; 4:697-728.
3. Koskiniemi M. CNS manifestations associated with Mycoplasma pneumoniae infections: summary of cases at the University of Helsinki and review. Clin Infect Dis 1993; 17 (Suppl 1):S52-S57.
4. Tsiodras S, Kelesidis I, Kelesidis T, et al. Central nervous system manifestations of Mycoplasma pneumoniae infections. J Infect 2005; 51:343-354. Timely and comprehensive review of the CNS manifestations of M. pneumoniae infection.
5. Pönka A. Central nervous system manifestations associated with serologically verified Mycoplasma pneumoniae infection. Scand J Infect Dis 1980; 12:175-184.
6. Daxboeck F, Blacky A, Seidl R, et al. Diagnosis, treatment, and prognosis of Mycoplasma pneumoniae childhood encephalitis: systematic review of 58 cases. J Child Neurol 2004; 19:865-871.
7. Kolski H, Ford-Jones EL, Richardson S, et al. Etiology of acute childhood encephalitis at The Hospital for Sick Children, Toronto, 1994-1995. Clin Infect Dis 1998; 26:398-409.
8. Bitnun A, Ford-Jones E, Blaser S, Richardson S. Mycoplasma pneumoniae encephalitis. Semin Pediatr Infect Dis 2003; 14:96-107.
9. Jacobs BC, Rothbarth PH, van der Meche FG, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 1998; 51:1110-1115.
10. Guleria R, Nisar N, Chawla TC, Biswas NR. Mycoplasma pneumoniae and central nervous system complications: a review. J Lab Clin Med 2005; 146:55-63. Timely and comprehensive review of the CNS manifestations of M. pneumoniae infection.
11. Müller N, Riedel M, Blendinger C, et al. Mycoplasma pneumoniae infection and Tourette's syndrome. Psychiatry Res 2004; 129:119-125.
12. Koga M, Gilbert M, Li J, et al. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology 2005; 64:1605-1611. Case-control study indicating that M. pneumoniae is not associated with Fisher syndrome. Although the study population was comparatively small (73 cases), this is a notable negative report on the association of M. pneumoniae and neurologic disease.
13. Masutani S, Takayama R, Tsugawa T, et al. Intracranial hypertension in a boy with Mycoplasma pneumoniae infection: the first report. Scand J Infect Dis 2004; 36:700-701.
14. Auvichayapat N, Auvichayapat P, Watanatorn J, et al. Kluver-Bucy syndrome after mycoplasmal bronchitis. Epilepsy Behav 2005 Dec 12 [Epub ahead of print] First report on Kluver-Bucy syndrome associated with M. pneumoniae infection.
15. Mittelbronn M, Wolff M, Bultmann E, et al. Disseminating anaplastic brainstem oligodendroglioma associated with allelic loss in the tumor suppressor candidate region D19S246 of chromosome 19 mimicking an inflammatory central nervous system disease in a 9-year-old boy. Hum Pathol 2005; 36:854-857.
16. Trad S, Ghosn J, Dormont D, et al. Nuclear bilateral Bell's palsy and ageusia associated with Mycoplasma pneumoniae pulmonary infection. J Med Microbiol 2005; 54:417-419. Well enrolled case of this rare neurologic manifestation of M. pneumoniae infection providing MRI findings.
17. Termine C, Uggetti C, Veggiotti P, et al. Long-term follow-up of an adolescent who had bilateral striatal necrosis secondary to Mycoplasma pneumoniae infection. Brain Dev 2005; 27:62-65. One of the rare reports on the long-termfollow-up of M. pneumoniae CNS disease.
18. Aydin A, Atasever S, Cakmakci H. Acute disseminated encephalomyelitis presenting with bilateral transient amaurosis. Pediatr Neurol 2005; 32:60-63.
19. Candler PM, Dale RC. Three cases of central nervous system complications associated with Mycoplasma pneumoniae. Pediatr Neurol 2004; 31:133-138.
20. Ginestal RC, Plaza JF, Callejo JM, et al. Bilateral optic neuritis and Guillain-Barré syndrome following an acute Mycoplasma pneumoniae infection. J Neurol 2004; 251:767-768.
21. Heatwole CR, Berg MJ, Henry JC, Hallman JL. Extreme spindles: a distinctive EEG pattern in Mycoplasma pneumoniae encephalitis. Neurology 2005; 64:1096-1097.
22. Leonardi S, Pavone P, Rotolo N, La Rosa M. Stroke in two children with Mycoplasma pneumoniae infection: a causal or casual relationship? Pediatr Infect Dis J 2005; 24:843-845.
23. Ngeh J, Goodbourn C. Chlamydia pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila in elderly patients with stroke (C-PEPS, M-PEPS, L-PEPS): a case-control study on the infectious burden of atypical respiratory pathogens in elderly patients with acute cerebrovascular disease. Stroke 2005; 36:259-265. A representative study on the association of M. pneumoniae infection and stroke.
24. Matsuo M, Tsuchiya K, Hamasaki Y, Singer HS. Restless legs syndrome: association with streptococcal or mycoplasma infection. Pediatr Neurol 2004; 31:119-121.
25. Manteau C, Liet JM, Caillon J, et al. Acute severe spinal cord dysfunction in a child with meningitis: Streptococcus pneumoniae and Mycoplasma pneumoniae co-infection. Acta Paediatr 2005; 94:1339-1341.
26. Weinberg A, Bloch KC, Li S, et al. Dual infections of the central nervous system with Epstein-Barr virus. J Infect Dis 2005; 191:234-237.
27. Bitnun A, Ford-Jones EL, Petric M, et al. Acute childhood encephalitis and Mycoplasma pneumoniae. Clin Infect Dis 2001; 32:1674-1684.
28. Socan M, Ravnik I, Bencina D, et al. Neurological symptoms in patients whose cerebrospinal fluid is culture- and/or polymerase chain reaction-positive for Mycoplasma pneumoniae. Clin Infect Dis 2001; 32:E31-E35.
29. Fleischhauer P, Hüben U, Mertens H, et al. Nachweis von Mycoplasma pneumoniae im Liquor bei akuter Polyneuritis [in German]. Dtsch Med Wochenschr 1972; 97:678-682.
30. Narita M, Matsuzono Y, Itakura O, et al. Survey of mycoplasmal bacteremia detected in children by polymerase chain reaction. Clin Infect Dis 1996; 23:522-525.
31. Daxboeck F, Khanakah G, Bauer C, et al. Detection of Mycoplasma pneumoniae in serum specimens from patients with mycoplasma pneumonia by PCR. Int J Med Microbiol 2005; 295:279-285. Largest study on the detection by PCR of M. pneumoniae from blood in patients with mycoplasma pneumonia.
32. Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 1998; 62:1094-1156.
33. Biberfeld G. Antibodies to brain and other tissues in cases of Mycoplasma pneumoniae infection. Clin Exp Immunol 1971; 8:319-833.
34. Nishimura M, Saida T, Kuroki S, et al. Post-infectious encephalitis with anti-galactocerebroside antibody subsequent to Mycoplasma pneumoniae infection. J Neurol Sci 1996; 140:91-95.
35. Ang CW, Tio-Gillen AP, Groen J, et al. Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barré syndrome. J Neuroimmunol 2002; 130:179-183.
36. Arakawa H, Yuhara Y, Todokoro M, et al. Immunoadsorption therapy for a child with Guillain-Barré syndrome subsequent to Mycoplasma infection: a case study. Brain Dev 2005; 27:431-433. Interesting report on the sucessful treatment of M. pneumoniae-associated Guillain-Barré syndrome by immunoadsorption therapy.
37. Narita M, Tanaka H, Togashi T, Abe S. Cytokines involved in CNS manifestations caused by Mycoplasma pneumoniae. Pediatr Neurol 2005; 33:105-109. First study of the cytokine levels in serum and CSF in patients with M. pneumoniae CNS disease.
38. Bencina D, Dovc P, Mueller-Premru M, et al. Intrathecal synthesis of specific antibodies in patients with invasion of the central nervous system by Mycoplasma pneumoniae. Eur J Clin Microbiol Infect Dis 2000; 19:521-530.
39. Jacobs E. Serological diagnosis of Mycoplasma pneumoniae infections: a critical review of current procedures. Clin Infect Dis 1993; 17 (Suppl 1):S79-S82.
40. Kleemola M, Kayhty H. Increase in titers of antibodies to Mycoplasma pneumoniae in patients with purulent meningitis. J Infect Dis 1982; 146:284-288.
41. de Ory F, Guisasola ME, Coccola F, et al. Evaluation of an automated complement-fixation test (Seramat) for diagnosis of acute respiratory infections caused by viruses and atypical bacteria. Clin Microbiol Infect 2004; 10:220-223.
42. Barker CE, Sillis F, Wreghitt TG. Evaluation of Serodia Myco II particle agglutination test for detection of Mycoplasma pneumoniae antibody: comparison with m-capture ELISA and indirect immunofluorescence. J Clin Pathol 1991; 43:163-165.
43. Watkins-Riedel T, Stanek G, Daxboeck F. Comparison of SeroMP IgA with four other commercial assays for serodiagnosis of Mycoplasma pneumoniae pneumonia. Diagn Microbiol Infect Dis 2001; 40:21-25.
44. Beersma MF, Dirven K, van Dam AP, et al. Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard". J Clin Microbiol 2005; 43:2277-2285. Comprehensive study on the diagnostic accuracy of commercial assays for detection of anti-M. pneumoniae antibodies.
45. Talkington DF, Shott S, Fallon MT, et al. Analysis of eight commercial enzyme immunoassay tests for detection of antibodies to Mycoplasma pneumoniae in human serum. Clin Diagn Lab Immunol 2004; 11:862-867.
46. Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect 2003; 9:263-273.
47. Saito R, Misawa Y, Moriya K, et al. Development and evaluation of a loop-mediated isothermal amplification assay for rapid detection of Mycoplasma pneumoniae. J Med Microbiol 2005; 54:1037-1041.
48. Ginevra C, Barranger C, Ros A, et al. Development and evaluation of Chlamylege, a new commercial test allowing simultaneous detection and identification of Legionella, Chlamydophila pneumoniae, and Mycoplasma pneumoniae in clinical respiratory specimens by multiplex PCR. J Clin Microbiol 2005; 43:3247-3254.
49. Morozumi M, Hasegawa K, Kobayashi R, et al. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob Agents Chemother 2005; 49:2302-2306. One of the few large studies on the in-vitro antimicrobial resistance of M. pneumoniae, providing the molecular characterization of resistant strains.
50. Matsuoka M, Narita M, Okazaki N, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother 2004; 48:4624-4630.
51. Gruson D, Pereyre S, Renaudin H, et al. In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively. Antimicrob Agents Chemother 2005; 49:1190-1193.
52. Bebear CM, Pereyre S. Mechanisms of drug resistance in Mycoplasma pneumoniae. Curr Drug Targets Infect Disord 2005; 5:263-271. Comprehensive review of the the present knowledge on in-vitro antimicrobial resistance of M. pneumoniae.
53. Carpenter TC. Corticosteroids in the treatment of severe mycoplasma encephalitis in children. Crit Care Med 2002; 30:925-927.
54. Sheth RD, Goulden KJ, Pryse-Phillips WE. The focal encephalopathies associated with Mycoplasma pneumoniae. Can J Neurol Sci 1993; 20: 319-323.
55. Cotter FE, Bainbridge D, Newland AC. Neurological deficit associated with Mycoplasma pneumoniae reversed by plasma exchange. Br Med J (Clin Res Ed) 1983; 286:22.
56. Sakoulas G. Brainstem and striatal encephalitis complicating Mycoplasma pneumoniae pneumonia: possible benefit of intravenous immunoglobulin. Pediatr Infect Dis J 2001; 20:543-545.